Search results for "Polyglycolic Acid"

showing 10 items of 24 documents

Improvement of osteogenic differentiation of human mesenchymal stem cells on composite poly l-lactic acid/nano-hydroxyapatite scaffolds for bone defe…

2020

Tissue engineering offers new approaches to repair bone defects, which cannot be repaired physiologically, developing scaffolds that mimic bone tissue architecture. Furthermore, biomechanical stimulation induced by bioreactor, provides biomechanical cues that regulate a wide range of cellular events especially required for cellular differentiation and function. The improvement of human mesenchymal stem cells (hMSCs) colonization in poly-L-lactic-acid (PLLA)/nano- hydroxyapatite (nHA) composite scaffold was evaluated in terms of cell proliferation (dsDNA content), bone differen- tiation (gene expression and protein synthesis) and ultrastructural analysis by comparing static (s3D) and dynamic…

0106 biological sciences0301 basic medicine3D cultureScaffoldCellular differentiationBioreactorBioengineeringBone tissue01 natural sciencesApplied Microbiology and BiotechnologyBone and BonesCell Line03 medical and health sciencesBioreactorsTissue engineeringPolylactic Acid-Polyglycolic Acid CopolymerPoly-L-lactic-acid/nano-hydroxyapatiteOsteogenesis010608 biotechnologyOsteogenic differentiation w/o growth factorsmedicineHumansBone regenerationCell ProliferationComposite scaffoldSettore ING-IND/24 - Principi Di Ingegneria ChimicaTissue EngineeringTissue ScaffoldsChemistryMesenchymal stem cell3D culture; Bioreactor; Composite scaffold; Osteogenic differentiation w/o growth factors; Poly-L-lactic-acid/nano-hydroxyapatite; Bioreactors; Bone and Bones; Cell Differentiation; Cell Line; Cell Proliferation; Durapatite; Humans; Mesenchymal Stem Cells; Osteogenesis; Polylactic Acid-Polyglycolic Acid Copolymer; Tissue Engineering; Tissue ScaffoldsSettore ING-IND/34 - Bioingegneria IndustrialeCell DifferentiationMesenchymal Stem CellsCell biologyRUNX2030104 developmental biologymedicine.anatomical_structureDurapatiteCell cultureBiotechnologyJournal of bioscience and bioengineering
researchProduct

Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model

2017

The therapy of inflammatory bowel diseases is still rather inefficient, and about 80% of patients require surgery at some stage. Improving the treatments by more efficient medication is, therefore, an urgent medical need. The objective of this project was to demonstrate targeted delivery of Cyclosporine-A (CYA) to the inflamed areas of the intestinal mucosa after oral administration, enabling improved alleviation of the symptoms and, at the same time, reduced systemic drug absorption and associated adverse effects. As had already been demonstrated in previous studies, nano- to micrometer-sized drug particles will accumulate at inflamed mucosal areas, providing a platform for such purposes. …

0301 basic medicineDrugColonPolymersmedia_common.quotation_subjectAdministration OralBiological AvailabilityPharmaceutical Science02 engineering and technologyPharmacologyInflammatory bowel diseaseMice03 medical and health sciencesDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIntestinal mucosaOral administrationAnimalsMedicineLactic AcidIntestinal MucosaParticle SizeAdverse effectmedia_commonDrug CarriersMice Inbred BALB CCrohn's diseasebusiness.industryGeneral MedicineInflammatory Bowel Diseases021001 nanoscience & nanotechnologymedicine.diseaseBioavailabilityDisease Models Animal030104 developmental biologyCyclosporineNanoparticlesNanocarriers0210 nano-technologybusinessPolyglycolic AcidBiotechnologyEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

A two-cohort feasibility study on polyglycolic acid yarn implantation for abolition of saphenous vein reflux

2017

The objective of this study was to evaluate the feasibility and safety of a polyglycolic acid (PGA) yarn implant for nonthermal ablation of saphenous vein reflux.In two consecutive cohort studies (TAHOE I and TAHOE II), the feasibility of abolition of great saphenous vein (GSV) reflux by implantation of a PGA yarn was tested under ultrasound guidance in 51 and 30 patients, respectively. The use of tumescent local anesthesia was not required. Graduated compression stockings and thrombosis prophylaxis with low-molecular-weight heparin were used for 2 weeks after intervention in the first study only.Of 81 enrolled patients, 77 (95%) were available at 6-month follow-up. Complete occlusion of th…

AdultMalemedicine.medical_specialtyTime FactorsBiocompatible MaterialsKaplan-Meier Estimate030204 cardiovascular system & hematologyVaricose Ulcer03 medical and health sciences0302 clinical medicineFibrinolytic AgentsAbsorbable ImplantsOcclusionmedicineHumansSaphenous VeinLocal anesthesia030212 general & internal medicineVeinUltrasonography InterventionalAgedRetrospective StudiesUltrasonography Doppler DuplexWound Healingbusiness.industryDominican RepublicEndovascular ProceduresGreat saphenous veinRefluxRetrospective cohort studyMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryEuropeTreatment Outcomemedicine.anatomical_structureVenous InsufficiencyFeasibility StudiesFemaleSurgeryCardiology and Cardiovascular MedicinebusinessPolyglycolic AcidStockings CompressionJournal of Vascular Surgery: Venous and Lymphatic Disorders
researchProduct

New gellan gum-graft-poly(D,L-lactide-co-glycolide) copolymers as promising bioinks: Synthesis and characterization

2020

This research focused on the aim of tackling the urgent demand of printable biomaterials, hence we synthetized and characterized three gellan gum-graft-poly(d,l-lactide-co-glycolide) copolymers (GGm-PLGA a, b and c) which differed in the graft substitution degree. We investigated the effect of the polyester chain grafted onto hydrophilic backbone of gellan gum in terms of physicochemical properties and the ability of the system to print 3D cell laden constructs. In particular, we evaluated thermo-rheological, ionotropic crosslinking, shear thinning, swelling and stability properties of these copolymers and their derived biomaterials and findings related to the degree of functionalization. M…

Biocompatible Materials02 engineering and technologyBiochemistry03 medical and health scienceschemistry.chemical_compoundMicePolylactic Acid-Polyglycolic Acid CopolymerGraft copolymersStructural BiologyMaterials TestingmedicineCopolymerAnimalsMolecular Biology030304 developmental biologyMechanical Phenomena0303 health sciencesShear thinningTissue EngineeringChemistryPolysaccharides BacterialBioprintingGeneral Medicine3T3 Cells021001 nanoscience & nanotechnologyGellan gumPolyesterChemical engineeringSurface modificationPoly d l lactideInkPoly (DL-lactide-co-glycolide) (PLGA)Swellingmedicine.symptom0210 nano-technologyRheologyGellan gum (GG)
researchProduct

Characterization and biodistribution of Au nanoparticles loaded in PLGA nanocarriers using an original encapsulation process

2021

Due to their imaging and radiosensitizing properties, ultrasmall gadolinium chelate-coated gold nanoparticles (AuNP) represent a promising approach in the diagnosis and the treatment of tumors. However, their poor pharmacokinetic profile, especially their rapid renal clearance prevents from an efficient exploitation of their potential for medical applications. The present study focuses on a strategy which resides in the encapsulation of AuNP in large polymeric NP to avoid the glomerular filtration and then to prolong the vascular residence time. An original encapsulation procedure using the polyethyleneimine (PEI) was set up to electrostatically entrap AuNP in biodegradable poly(lactic-co-g…

BiodistributionGadoliniumMetal NanoparticlesNanoparticlechemistry.chemical_elementmacromolecular substances02 engineering and technologyPolyethylene glycol01 natural sciencesPolyethylene Glycolschemistry.chemical_compoundColloid and Surface ChemistryPolylactic Acid-Polyglycolic Acid Copolymer0103 physical sciencesAnimalsTissue DistributionParticle SizePhysical and Theoretical ChemistryDrug Carriers010304 chemical physicstechnology industry and agricultureSurfaces and InterfacesGeneral Medicine021001 nanoscience & nanotechnologyRatsEncapsulation (networking)PLGAchemistryColloidal goldBiophysicsNanoparticlesGoldNanocarriers0210 nano-technologyBiotechnologyColloids and Surfaces B: Biointerfaces
researchProduct

PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses

2021

Contains fulltext : 232076.pdf (Publisher’s version ) (Open Access) Tumor-specific neoantigens can be highly immunogenic, but their identification for each patient and the production of personalized cancer vaccines can be time-consuming and prohibitively expensive. In contrast, tumor-associated antigens are widely expressed and suitable as an off the shelf immunotherapy. Here, we developed a PLGA-based nanoparticle vaccine that contains both the immunogenic cancer germline antigen NY-ESO-1 and an α-GalCer analog IMM60, as a novel iNKT cell agonist and dendritic cell transactivator. Three peptide sequences (85-111, 117-143, and 157-165) derived from immunodominant regions of NY-ESO-1 were se…

CD4-Positive T-Lymphocyteslcsh:Immunologic diseases. AllergyCancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2]T cellmedicine.medical_treatment[SDV]Life Sciences [q-bio]ImmunologyCD8-Positive T-Lymphocyteschemistry.chemical_compoundPolylactic Acid-Polyglycolic Acid CopolymerAntigenmedicinepeptide vaccineHumansImmunology and AllergyCytotoxic T cellNY-ESO-1B cellOriginal ResearchB-LymphocytesDrug CarriersDendritic cellImmunotherapyCD4 T cellPLGA nanoparticleIMM60Peptide FragmentsNeoplasm Proteins[SDV] Life Sciences [q-bio]PLGAmedicine.anatomical_structurechemistryCD8 T cellCancer researchB cell epitopeiNKT cellNanoparticleslcsh:RC581-607CD8
researchProduct

Amorphous polyphosphate/amorphous calcium carbonate implant material with enhanced bone healing efficacy in a critical-size defect in rats

2016

In this study the effect of amorphous calcium carbonate (ACC) microparticles and amorphous calcium polyphosphate (polyP) microparticles (termed aCa-polyP-MP) on bone mineral forming cells/tissue was investigated in vitro and in vivo. The ACC particles (termed ACC-P10-MP) were prepared in the presence of Na-polyP. Only the combinations of polyP and ACC microparticles enhanced the proliferation rate of human mesenchymal stem cells (MSCs). Gene expression studies revealed that ACC causes an upregulation of the expression of the cell membrane-associated carbonic anhydrase IX (CA IX; formation of ACC), while the transcript level of the alkaline phosphatase (ALP; liberation of orthophosphate from…

Calcium PhosphatesMale0301 basic medicineBone RegenerationMaterials scienceBiomedical Engineeringchemistry.chemical_elementBioengineering02 engineering and technologyBone healingCalciumRats Sprague-DawleyBiomaterials03 medical and health scienceschemistry.chemical_compoundPolylactic Acid-Polyglycolic Acid CopolymerOsteogenesisPolyphosphatesIn vivoElastic ModulusPressureAnimalsHumansLactic AcidBone regenerationOsteoblastsTissue ScaffoldsMesenchymal Stem CellsAlkaline Phosphatase021001 nanoscience & nanotechnologyMolecular biologyMicrospheresdigestive system diseasesAmorphous calcium carbonateRatsstomatognathic diseasesPLGA030104 developmental biologychemistryAlkaline phosphataseLiberationStress Mechanical0210 nano-technologyPolyglycolic AcidBiomedical engineeringBiomedical Materials
researchProduct

Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots

2021

Contains fulltext : 244693.pdf (Publisher’s version ) (Open Access) Synthetic cancer vaccines may boost anticancer immune responses by co-delivering tumor antigens and adjuvants to dendritic cells (DCs). The accessibility of cancer vaccines to DCs and thereby the delivery efficiency of antigenic material greatly depends on the vaccine platform that is used. Three-dimensional scaffolds have been developed to deliver antigens and adjuvants locally in an immunostimulatory environment to DCs to enable sustained availability. However, current systems have little control over the release profiles of the cargo that is incorporated and are often characterized by an initial high-burst release. Here,…

Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2]T-LymphocytesT cellBiomedical Engineering02 engineering and technologySDG 3 – Goede gezondheid en welzijnantigen-specific T cellsCancer VaccinesArticleBiomaterials03 medical and health sciencesbiomaterial-based scaffoldsImmune systemAntigenSDG 3 - Good Health and Well-beingAntigen specificControlled deliverymedicineLactic Aciddendritic cells030304 developmental biology0303 health sciencesChemistryBiomaterial021001 nanoscience & nanotechnologyCell biologymedicine.anatomical_structureDelivery efficiencynanoparticles0210 nano-technologycancer vaccinationNanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19]Polyglycolic Acid
researchProduct

Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges.

2015

Hyaluronic acid (HA) is a biodegradable, biocompatible, nontoxic, and non-immunogenic glycosaminoglycan used for various biomedical applications. The interaction of HA with the CD44 receptor, whose expression is elevated on the surface of many types of tumor cells, makes this polymer a promising candidate for intracellular delivery of imaging and anticancer agents exploiting a receptor-mediated active targeting strategy. Therefore, HA and its derivatives have been most investigated for the development of several carrier systems intended for cancer diagnosis and therapy. Nonetheless, different and important delivery applications of the polysaccharide have also been described, including gene …

Diagnostic ImagingCarbon nanotubes; Drug delivery; Hyaluronic acid; Intracellular delivery; Quantum dots; TheranosticsPolyestersCarbon nanotubesAcrylic ResinsPharmaceutical ScienceTumor cellsNanotechnologyPolyethylene Glycolschemistry.chemical_compoundDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerHyaluronic acidMedicineHumansLactic AcidHyaluronic Acidbusiness.industryQuantum dotsNanotubes CarbonHydrogelsGeneral MedicineIntracellular deliveryBiocompatible materialTheranosticschemistryDrug deliveryDrug deliveryNanocarriersbusinessPolyglycolic AcidBiotechnologyEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Predictability of drug encapsulation and release from propylene carbonate/PLGA microparticles.

2020

Abstract Key parameters for microparticle-based parenteral depot formulation development are entrapment efficiency and sustained drug release, which both depend on the intermolecular affinity of the components. Here, partial solubility parameters were evaluated as descriptors for 21 drug substances and 3 polymers in propylene carbonate (PC). Out of these 21 drug substances, eight BCS class II substances (celecoxib, clotrimazole, erythromycin, ibuprofen, indomethacin, itraconazole, lopinavir and ritonavir) were encapsulated using PLGA (Poly(DL-lactide-co-glycolide)) as polymer matrix and PC as a polar aprotic solvent in order to assign microparticle properties to potential affinity-related i…

Drug CompoundingPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compoundPropane0302 clinical medicinePolylactic Acid-Polyglycolic Acid CopolymermedicineLactic AcidMicroparticleSolubilityParticle SizeChemistry021001 nanoscience & nanotechnologyIbuprofenMicrospheresSolventHildebrand solubility parameterPLGAChemical engineeringPharmaceutical PreparationsSolubilityPropylene carbonate0210 nano-technologyGlass transitionPolyglycolic Acidmedicine.drugInternational journal of pharmaceutics
researchProduct